May 6, 2026

Biotech IPOs and Investor Relations Available Now!

Over the two years, New Street IR has published a growing library of content focused on one core objective: helping biotech companies better understand how to navigate the ins and outs of Wall Street.

From IPO preparation and investor targeting to analyst coverage, messaging, and long-term capital strategy, the blog has become a resource for executives looking for clear, actionable guidance in a complex and volatile market.

Today, we are pleased to announce the release of Biotech IPOs and Investor Relations, a comprehensive, 400+ page book authored by our Founder and CEO, Laurence Watts.

The book builds on the foundation of the blog and takes it a step further.

Rather than a series of standalone posts, Biotech IPOs and Investor Relations is fully structured and organized by topic, allowing readers to quickly navigate to the areas most relevant to them. Whether preparing for a financing round, evaluating IPO readiness, or refining an investor communications strategy, the book is designed to serve as a practical reference guide.

In an industry where access to capital is critical, and where small strategic decisions can have outsized impacts, having the right framework matters.

The book is available now. Reach out to obtain a free copy or order from Amazon here.